• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国广州地区患者的抗生素耐药率

Prevalence of Antibiotic Resistance in Patients Enrolled in Guangzhou, China.

作者信息

Deng RiHui, Liu LiYan, Xie WeiKe, Lu Weiguo, Liu Zhihui, Wang Yang

机构信息

Department of Clinical Laboratory, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.

Shanghai Xinchao Medical Laboratory, Shanghai, People's Republic of China.

出版信息

Infect Drug Resist. 2023 Aug 3;16:5033-5038. doi: 10.2147/IDR.S418482. eCollection 2023.

DOI:10.2147/IDR.S418482
PMID:37554543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10406106/
Abstract

PURPOSE

() infection is a high-risk factor for the occurrence of gastric cancer. The quadruple therapy has been widely used as the first-line treatment for in China. However, the increasing resistance rate to antibiotics has become a major challenge in the treatment of . Therefore, there is an urgent need for rapid and cost-effective detection of antibiotic resistance to different antibiotics. To evaluate the prevalence of antibiotic resistance in Guangzhou and the diagnostic performance of DOB value of 13C UBT in predicting antibiotic resistance.

PATIENTS AND METHODS

In this retrospective study, we collected data from 193 culture-positive patients in Guangzhou on their DOB values and resistance to antibiotics. We analyzed the antibiotic resistance rate of commonly used antibiotics in quadruple therapy, and the diagnostic efficacy of DOB value was evaluated.

RESULTS

The resistance rates of clarithromycin (CLA) and levofloxacin (LEV) were 46.1% and 44.0%, respectively. In the age group under 40, the resistance rate of LEV was lower than that of CLA. However, the diagnostic efficacy of DOB value was found to be low and it could not serve as an independent indicator for diagnosing resistance to CLA and LEV.

CONCLUSION

The high resistance rates of CLA and LEV in patients in Guangzhou indicate the urgent need for effective detection methods. The DOB value is not a direct indicator of antibiotic resistance to CLA and LEV. Therefore, it is important to use a combination of diagnostic methods to accurately assess antibiotic resistance in infection.

摘要

目的

()感染是胃癌发生的高危因素。四联疗法在中国已被广泛用作()的一线治疗方法。然而,抗生素耐药率的不断上升已成为()治疗中的一项重大挑战。因此,迫切需要快速且经济高效地检测对不同抗生素的耐药性。评估广州地区()抗生素耐药性的流行情况以及13C尿素呼气试验(UBT)的DOB值在预测抗生素耐药性方面的诊断性能。

患者与方法

在这项回顾性研究中,我们收集了广州193例()培养阳性患者的DOB值和抗生素耐药数据。我们分析了四联疗法中常用抗生素的耐药率,并评估了DOB值的诊断效能。

结果

克拉霉素(CLA)和左氧氟沙星(LEV)的耐药率分别为46.1%和44.0%。在40岁以下年龄组中,LEV的耐药率低于CLA。然而,发现DOB值的诊断效能较低,它不能作为诊断CLA和LEV耐药性的独立指标。

结论

广州地区()患者中CLA和LEV的高耐药率表明迫切需要有效的检测方法。DOB值不是CLA和LEV抗生素耐药性的直接指标。因此,采用多种诊断方法相结合来准确评估()感染中的抗生素耐药性很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08a3/10406106/11d0daba4702/IDR-16-5033-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08a3/10406106/11d0daba4702/IDR-16-5033-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08a3/10406106/11d0daba4702/IDR-16-5033-g0001.jpg

相似文献

1
Prevalence of Antibiotic Resistance in Patients Enrolled in Guangzhou, China.中国广州地区患者的抗生素耐药率
Infect Drug Resist. 2023 Aug 3;16:5033-5038. doi: 10.2147/IDR.S418482. eCollection 2023.
2
Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years.中国东南地区儿童幽门螺杆菌的抗生素耐药性令人震惊,这一情况已持续了 6 年以上。
Sci Rep. 2022 Oct 22;12(1):17754. doi: 10.1038/s41598-022-21661-y.
3
Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study.中国患者幽门螺杆菌的主要抗生素耐药性:一项多地区前瞻性 7 年研究。
Clin Microbiol Infect. 2018 Jul;24(7):780.e5-780.e8. doi: 10.1016/j.cmi.2017.11.010. Epub 2017 Nov 11.
4
Phenotype and Molecular Detection of Clarithromycin and Levofloxacin Resistance in Clinical Isolates in Beijing.北京临床分离株中克拉霉素和左氧氟沙星耐药性的表型及分子检测
Infect Drug Resist. 2020 Jul 6;13:2145-2153. doi: 10.2147/IDR.S249370. eCollection 2020.
5
High-dose amoxicillin-proton pump inhibitor dual therapy as first-line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial.高剂量阿莫西林-质子泵抑制剂双联疗法作为中国西北地区幽门螺杆菌感染的一线治疗:一项前瞻性、随机对照试验。
Br J Clin Pharmacol. 2023 Jan;89(1):232-241. doi: 10.1111/bcp.15488. Epub 2022 Aug 21.
6
Minimum inhibitory concentrations of commonly used antibiotics against Helicobacter Pylori: A multicenter study in South China.常用抗生素对幽门螺杆菌最低抑菌浓度:华南地区多中心研究。
PLoS One. 2021 Sep 2;16(9):e0256225. doi: 10.1371/journal.pone.0256225. eCollection 2021.
7
Helicobacter pylori antibiotic resistance and [13C]urea breath test values.幽门螺杆菌抗生素耐药性和 [13C]尿素呼气试验值。
J Med Microbiol. 2010 May;59(Pt 5):588-591. doi: 10.1099/jmm.0.018077-0. Epub 2010 Jan 21.
8
13C-urea breath test to diagnose Helicobacter pylori infection in children aged up to 6 years.13C-尿素呼气试验用于诊断6岁及以下儿童的幽门螺杆菌感染。
Helicobacter. 2004 Feb;9(1):39-45. doi: 10.1111/j.1083-4389.2004.00196.x.
9
Can 13C urea breath test predict resistance to therapy in Helicobacter pylori infection?13C尿素呼气试验能否预测幽门螺杆菌感染的治疗耐药性?
Hepatogastroenterology. 2005 Jul-Aug;52(64):1119-21.
10
Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children.抗药性与斯洛文尼亚儿童分离的幽门螺杆菌菌株中特定三联疗法的成功。
Helicobacter. 2017 Oct;22(5). doi: 10.1111/hel.12400. Epub 2017 Jun 27.

本文引用的文献

1
2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment.2022 中国国家临床实践指南:幽门螺杆菌根除治疗。
Chin Med J (Engl). 2022 Dec 20;135(24):2899-2910. doi: 10.1097/CM9.0000000000002546.
2
Antibiotics Resistance Prevalence of Strains in Northwest China.中国西北地区菌株的抗生素耐药性流行情况
Infect Drug Resist. 2022 Sep 20;15:5519-5528. doi: 10.2147/IDR.S383444. eCollection 2022.
3
High-dose amoxicillin-proton pump inhibitor dual therapy as first-line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial.
高剂量阿莫西林-质子泵抑制剂双联疗法作为中国西北地区幽门螺杆菌感染的一线治疗:一项前瞻性、随机对照试验。
Br J Clin Pharmacol. 2023 Jan;89(1):232-241. doi: 10.1111/bcp.15488. Epub 2022 Aug 21.
4
Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients.智利患者中幽门螺杆菌耐药的流行情况。
Arch Med Res. 2021 Jul;52(5):529-534. doi: 10.1016/j.arcmed.2021.01.011. Epub 2021 Feb 12.
5
Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in .比较 qPCR、Sanger 测序和全基因组测序在确定 中克拉霉素和左氧氟沙星耐药性的诊断性能。
Front Cell Infect Microbiol. 2020 Dec 17;10:596371. doi: 10.3389/fcimb.2020.596371. eCollection 2020.
6
Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for infection.铋剂四联疗法中阿莫西林或四环素作为一线治疗 感染。
Gut Microbes. 2020 Sep 2;11(5):1314-1323. doi: 10.1080/19490976.2020.1754118. Epub 2020 May 2.
7
Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line treatment: a multicentre randomised trial in Japan.七日 vonoprazan 与低剂量阿莫西林双联疗法作为一线治疗:日本多中心随机试验。
Gut. 2020 Jun;69(6):1019-1026. doi: 10.1136/gutjnl-2019-319954. Epub 2020 Jan 8.
8
Helicobacter pylori Infections in the Bronx, New York: Surveying Antibiotic Susceptibility and Strain Lineage by Whole-Genome Sequencing.纽约布朗克斯的幽门螺杆菌感染:通过全基因组测序调查抗生素耐药性和菌株谱系。
J Clin Microbiol. 2020 Feb 24;58(3). doi: 10.1128/JCM.01591-19.
9
Infection Aggravates Dysbiosis of Gut Microbiome in Children With Gastritis.感染会加重胃炎患儿肠道微生物组的失调。
Front Cell Infect Microbiol. 2019 Nov 7;9:375. doi: 10.3389/fcimb.2019.00375. eCollection 2019.
10
Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps.幽门螺杆菌在宿主内的进化是由生态位特化适应、胃内迁移和选择清除塑造的。
Nat Commun. 2019 May 22;10(1):2273. doi: 10.1038/s41467-019-10050-1.